ReviewWorld journal of hepatology2016

How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma.

Jean-Luc Raoul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.